Increase in prevalence of leprosy caused by dapsone-resistant Mycobacterium leprae.
出版信息
MMWR Morb Mortal Wkly Rep. 1982 Jan 8;30(52):637-8.
PMID:6798411
Abstract
摘要
相似文献
1
Increase in prevalence of leprosy caused by dapsone-resistant Mycobacterium leprae.由耐氨苯砜麻风杆菌引起的麻风病患病率上升。
MMWR Morb Mortal Wkly Rep. 1982 Jan 8;30(52):637-8.
2
Dapsone drug resistance in the MDT era.多药联合治疗时代的氨苯砜耐药性。
Int J Lepr Other Mycobact Dis. 2000 Sep;68(3):323-5.
3
[Prevalence of dapsone-resistant leprosy in Burundi. Temporary results].[布隆迪耐氨苯砜麻风病的患病率。临时结果]
Acta Leprol. 1982 Jan-Jun(86-87):29-33.
4
Infectivity of secondary dapsone-resistant cases.继发氨苯砜耐药病例的传染性。
Int J Lepr Other Mycobact Dis. 1988 Sep;56(3):418-21.
5
Drug resistant leprosy--a comparison between proven dapsone and proven thiambutosine resistance.耐药性麻风病——氨苯砜耐药与氨硫脲耐药的比较
Int J Lepr Other Mycobact Dis. 1976 Jan-Jun;44(1-2):152-3.
6
Long-term treatment of dapsone-resistant leprosy with rifampicin: clinical and bacteriological studies.利福平对耐氨苯砜麻风病的长期治疗：临床与细菌学研究
Int J Lepr Other Mycobact Dis. 1976 Jan-Jun;44(1-2):159-69.
7
Primary dapsone-resistant leprosy in Cebu, Philippines.
Int J Lepr Other Mycobact Dis. 1981 Dec;49(4):427-30.
8
The problem of dapsone-resistant leprosy.
Int J Lepr Other Mycobact Dis. 1981 Dec;49(4):417-20.
9
Dapsone-resistant leprosy-the THELEP approach.
Int J Lepr Other Mycobact Dis. 1981 Dec;49(4):421-5.
10
The prevalence of dapsone-resistant leprosy in Israel.以色列氨苯砜耐药麻风病的患病率。
Lepr Rev. 1977 Jun;48(2):107-12. doi: 10.5935/0305-7518.19770012.
引用本文的文献
1
Thymopentin treatment in patients with chemotherapy-resistant lepromatous leprosy.胸腺五肽治疗耐化疗瘤型麻风患者。
Surv Immunol Res. 1985;4 Suppl 1:63-9. doi: 10.1007/BF02919058.
Zotero 插件